http://www.addexpharma.com/ Latest News en TYPO3 - get.content.right http://blogs.law.harvard.edu/tech/rss Tue, 23 Feb 2010 00:24:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-2009-financial-results/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-2009-financial-results/ Français (PDF)English (PDF)Deutsch (PDF) Geneva, Switzerland, 23 February 2010 ? Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today 2009 financial results and reviewed the status of its pipeline.Financial Highlights C... 2010 Tue, 23 Feb 2010 00:24:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-at-the-new-york-academy-of-sciences/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-at-the-new-york-academy-of-sciences/ Data on Promising Clinical-Stage Parkinson?s Disease Product Addex Discovery Capabilities Illustrated 2010 Wed, 17 Feb 2010 15:25:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-host-2009-financial-results-call-on-feb-23/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-host-2009-financial-results-call-on-feb-23/ Geneva, Switzerland, 16 February 2010 ? Addex Pharmaceuticals (SIX:ADXN), the allosteric modulation company, will discuss its 2009 full year financial results during a conference call and webcast for investors, analysts and the media on Tuesday, 23 F... 2010 Tue, 16 Feb 2010 17:01:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-adx71943-demonstrates-analgesic-effects-in-pain-models/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-adx71943-demonstrates-analgesic-effects-in-pain-models/ Français (PDF)Deutsch (PDF)English (PDF) Geneva, Switzerland, 8 February 2010 ? Addex Pharmaceuticals (SIX:ADXN), the allosteric modulation company, announced today that ADX71943 has demonstrated statistically significant analgesic-like effects in t... 2010 Mon, 08 Feb 2010 04:43:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/development-of-adx10059-ended-for-long-term-use/ http://www.addexpharma.com/press-releases/press-release-details/article/development-of-adx10059-ended-for-long-term-use/ Webcast Replay Geneva, Switzerland, 15 December 2009 ? Addex Pharmaceuticals (SIX:ADXN) announced today that based on preliminary review of the unblinded data from study 206, it has terminated development of ADX10059 for chronic indications, includi... 2009 Tue, 15 Dec 2009 13:35:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-ends-migraine-prevention-study/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-ends-migraine-prevention-study/ Webcast Replay Français (PDF)Deutsch (PDF)English (PDF)Geneva, Switzerland, 14 December 2009 ? Addex Pharmaceuticals (SIX:ADXN) announced today that it has decided to end prematurely the migraine prevention study 206. Routine safety monit... 2009 Mon, 14 Dec 2009 17:47:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-extends-parkinsons-disease-collaboration-with-merck-co-inc/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-extends-parkinsons-disease-collaboration-with-merck-co-inc/ Geneva, Switzerland, 2 December 2009 ? Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today the extension of its research collaboration with Merck & Co., Inc., through an affiliate, for an additional year. The collabor... 2009 Wed, 02 Dec 2009 00:55:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-adx48621-positive-primate-parkinsons-data/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-adx48621-positive-primate-parkinsons-data/ ADX48621 shows efficacy on both chorea and dystonia in PD-LID model 2009 Mon, 23 Nov 2009 20:46:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-adx10059-monotherapy-is-effective-on-gerd-symptoms-in-phase-iib-clinical-trial/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-adx10059-monotherapy-is-effective-on-gerd-symptoms-in-phase-iib-clinical-trial/ Primary and Secondary Endpoints AchievedWebcast Replay Français (PDF)Deutsch (PDF)English (PDF)Geneva, Switzerland, 16 November 2009 ? Addex Pharmaceuticals (SWX:ADXN), the allosteric modulation company, announced that it achieved statistically si... 2009 Sun, 15 Nov 2009 23:01:00 +0100 http://www.addexpharma.com/press-releases/press-release-details/article/addex-presents-adx10059-pd-lid-data-at-gpcr-drug-discovery-conference/ http://www.addexpharma.com/press-releases/press-release-details/article/addex-presents-adx10059-pd-lid-data-at-gpcr-drug-discovery-conference/ ADX10059 inhibited both Chorea and Dystonia induced by levodopa while maintaining the anti-parkinsonian effect of levodopa on PD symptoms 2009 Tue, 03 Nov 2009 07:17:00 +0100